Company profile: Lifebit
1.1 - Company Overview
Company description
- Provider of intelligent genomics solutions. Lifebit CloudOS enables unified, secure research over distributed big data, with in situ analysis and connection to disparate datasets for large-scale clinico-genomic programs. Lifebit REAL uses AI to analyze real world data, making biomedical data actionable and accessible for biobanks and genomics initiatives.
Products and services
- Lifebit CloudOS: Architects a modular platform for in situ DNA analysis, securely connecting disparate datasets and supporting large-scale clinico-genomic programs across distributed big data
- Lifebit REAL: Delivers an AI-driven system that analyzes real-world biomedical data, enabling biobanks and genomics initiatives to make datasets actionable and accessible at scale
- Unified Distributed Research: Produces industry-standard, secure unified research over distributed big data, enabling researchers to analyze DNA data in situ, connect disparate datasets, and generate meaningful insights like humans do.
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Lifebit
Allcyte
HQ: Austria
Website
- Description: Provider of functional drug testing in primary human material using the Pharmacoscopy high-content imaging platform and AI-supported image analysis pipelines to advance precision and personalized medicine for cancer patients and treating physicians, while supporting pharmaceutical companies in drug development.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Allcyte company profile →
CRIO
HQ: United States
Website
- Description: Provider of eSource technology and tools to streamline clinical research workflows, including a web-based system for direct data capture with real-time entry and monitoring, and Reviewer EDC, an interface integrating eSource with Electronic Data Capture to enable remote monitoring and data review.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full CRIO company profile →
Insilico Biotechnology
HQ: Germany
Website
- Description: Provider of bioprocess software and services.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Insilico Biotechnology company profile →
OpenEye
HQ: United States
Website
- Description: Provider of computational molecular design software and services, including the Orion Molecular Design Platform for cloud-based design and simulation (virtual screening, molecular dynamics, free energy predictions, quantum mechanics, sequence analysis), large-scale 2D/3D virtual screening, lead discovery and optimization, antibody discovery, and drug formulation; with strengths in 3D molecular shape and electrostatics analysis.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full OpenEye company profile →
CCT Research
HQ: United States
Website
- Description: Provider of embedded clinical trial services, conducting Phase II–IV studies in family medicine, neurology, dermatology, and vaccines by integrating research sites into physician offices. Operates a network of over 30 sites across the US with centralized staffing, data and regulatory management, patient recruitment, investigator partnerships, and site business development.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full CCT Research company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Lifebit
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Lifebit
2.2 - Growth funds investing in similar companies to Lifebit
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Lifebit
4.2 - Public trading comparable groups for Lifebit
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →